Novo Nordisk and Eli Lilly currently control 99% of the market, but their dominance may weaken as new entrants introduce ...

The trial included 1,206 randomised people with obesity or overweight and type 2 diabetes and a mean baseline body weight of ...

While drug developers work to mitigate the side effects associated with GLP-1–based obesity drugs, recent studies reveal that ...

Study finds calorie restriction, intermittent fasting, and ketogenic diets improve cellular energy production and combat ...

Avocados, fatty fish, salad dressing, nuts and yogurt are high-fat foods that can support weight loss. Fat provides energy ...

Not all body fat is the same when it comes to health and weight loss. Fat that sits just under the skin, called subcutaneous ...

Glp-1s cover a variety of drugs that are commonly used for weight loss, such as Ozempic, Wegovy and Mounjaro. And West Virginians used them at the highest rate ...

The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all ...

The weight-loss drug market is evolving at a rapid speed, with leading pharma companies including Novo Nordisk and Eli Lilly ...

Stanford researchers have discovered BRP, a naturally occurring peptide that suppresses appetite and promotes weight loss, ...

Beyond type 2 diabetes and weight loss, GLP-1 agonists can also help lower blood pressure, improve lipid disorders, reduce ...

Weight loss medication, such as GLP-1s and oral medications, can be useful for some to suppress your appetite and curb ...